GSA Capital Partners’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-930,718
| Closed | -$1.37M | – | 2017 |
|
|
2022
Q2 | $1.37M | Buy |
930,718
+462,882
| +99% | +$680K | 0.21% | 55 |
|
|
2022
Q1 | $538K | Buy |
467,836
+343,336
| +276% | +$395K | 0.07% | 476 |
|
|
2021
Q4 | $311K | Buy |
124,500
+52,848
| +74% | +$132K | 0.04% | 908 |
|
|
2021
Q3 | $367K | Buy |
+71,652
| New | +$367K | 0.04% | 893 |
|
|
2021
Q2 | – | Sell |
-64,143
| Closed | -$559K | – | 1705 |
|
|
2021
Q1 | $559K | Buy |
+64,143
| New | +$559K | 0.09% | 293 |
|
|
2020
Q4 | – | Sell |
-79,582
| Closed | -$949K | – | 1730 |
|
|
2020
Q3 | $949K | Buy |
+79,582
| New | +$949K | 0.16% | 112 |
|
|
2019
Q2 | – | Sell |
-24,742
| Closed | -$307K | – | 1828 |
|
|
2019
Q1 | $307K | Sell |
24,742
-18,024
| -42% | -$224K | 0.03% | 977 |
|
|
2018
Q4 | $263K | Buy |
+42,766
| New | +$263K | 0.03% | 917 |
|
|
2017
Q2 | – | Sell |
-22,000
| Closed | -$377K | – | 2034 |
|
|
2017
Q1 | $377K | Buy |
+22,000
| New | +$377K | 0.02% | 1263 |
|
|
2016
Q4 | – | Sell |
-38,860
| Closed | -$382K | – | 2026 |
|
|
2016
Q3 | $382K | Buy |
+38,860
| New | +$382K | 0.02% | 1213 |
|